US Stocks
/
Genelux Corporation Share Price

Genelux Corporation Share Price

NASDAQ: GNLX | Micro Cap
$2.73
+$0.06 (2.44%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Genelux Corporation Stock Performance

Open
$2.67
Prev. Close
$2.66
Circuit Range
N/A
Day Range
$2.62 - $2.71
Year Range
$2.29 - $8.46
Volume
15,431
Average Traded
$2.68

Genelux Corporation Share Price Today

As of 11 August 2026, Genelux Corporation's share price is $2.73. The stock opened at $2.67, compared to its previous close of $2.66. During today's trading session, Genelux Corporation's share price traded between $2.62 and $2.71, with an average price of $2.67. Over the past 52 weeks, the stock has recorded a high of $8.46 and a low of $2.29. In terms of performance, Genelux Corporation's share price has declined by 8.56% over the last six months and is down 17.67% on a year-on-year basis.

Genelux Corporation Share Price Chart

$2.62$2.71
L
Show Current Price
H

Genelux Corporation Stock Fundamentals & Key Indicators

Market Cap
$101.31M
PE Ratio (TTM)
-3.17
Dividend Yield
N/A
EPS (TTM)
$-0.86
Revenue (TTM)
$8000.00
Return On Equity (TTM)
-278.46%
Profit Margin
-401812.50%
Debt to Equity
0.54
Quarterly Earnings Growth YoY
-22.93%

Genelux Corporation Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$8000.00N/AN/AN/AN/AN/A
Net Profit-$7.85M-$6.58M-$6.47M-$7.49M-$7.46M-$7.95M
Net Profit Margin-98125.00%N/AN/AN/AN/AN/A
Income ChangeN/A16.23%1.66%-15.85%0.48%-6.63%

Genelux Corporation Annual Profit & Loss

All figures in USD

Particulars20232025
Revenue$170000.00$8000.00
Net Profit-$28.30M-$32.15M
Net Profit Margin-16645.29%-401812.50%
Income ChangeN/A-13.60%

About Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

Genelux Corporation Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.96
$2.71
-7.67%
Jul 2026
$3.01
$2.94
-2.81%
Jun 2026
$3.00
$3.02
-1.31%
May 2026
$2.67
$3.06
+14.82%
Apr 2026
$2.48
$2.67
+10.58%
Mar 2026
$2.84
$2.41
-19.13%
Feb 2026
$2.73
$2.98
+11.61%
Jan 2026
$4.54
$2.67
-38.69%
Dec 2025
$5.25
$4.36
-22.30%
Nov 2025
$7.92
$5.61
-30.55%
Oct 2025
$4.25
$8.07
+91.69%
Sep 2025
$3.40
$4.21
+27.19%

GNLX Share Price FAQs

What is Genelux Corporation share price today?

chevron-up
Genelux Corporation share price today is $2.73 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Genelux Corporation stock?

chevron-up
The 52 week high of Genelux Corporation stock is $8.46, while the 52 week low is $2.29 as of 11 Aug '26.

What is GNLX's market capitalisation today?

chevron-up
GNLX market capitalisation is $101.31M as of August 11, 2026, at 9:11 am IST.

What is GNLX's net income for the last quarter?

chevron-up
GNLX's net income for the last quarter is -0.01B USD.

What is the 5 year returns of GNLX?

chevron-up
The 5 year returns of GNLX is -52.42% as on 11 Aug '26.

What is the high & low stock price of GNLX today?

chevron-up
GNLX stock price hit a high of $2.71 and low of $2.62 as of 11 Aug '26.

Can I buy GNLX shares in India?

chevron-up
Yes. You can buy GNLX in India by opening an international trading account.